OncoCyte Corporation Common Stock

(NASDAQ:OCX)

Latest On OncoCyte Corporation Common Stock (OCX):

Date/Time Type Description Signal Details
2023-05-11 23:06 ESTNewsOncoCyte Corporation (OCX) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 08:52 ESTNewsOncoCyte GAAP EPS of $0.04 beats by $0.13, revenue of $0.3M misses by $0.04MN/A
2023-04-12 20:29 ESTNewsOncocyte cuts 20% of staffN/A
2023-04-04 01:14 ESTNewsOncocyte shares dip after pricing $13.86M stock offeringN/A
2023-04-04 01:14 ESTNewsOncoCyte Corporation (OCX) Q4 2022 Earnings Call TranscriptN/A
2023-04-03 06:58 ESTNewsOncoCyte reports Q4 resultsN/A
2023-03-29 01:24 ESTNewsOncoCyte Q4 2022 Earnings PreviewN/A
2023-03-02 20:08 ESTNewsOncocyte appoints CEON/A
2022-12-17 01:52 ESTNewsOncocyte cuts 40% of staff; to sell 70% stake in subsidiaryN/A
2022-11-20 03:20 ESTNewsOncoCyte: Between A Hammer And A Hard PlaceN/A
2022-11-11 14:41 ESTNewsOncoCyte Corporation (OCX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 21:11 ESTNewsOncoCyte GAAP EPS of -$0.08 beats by $0.03, revenue of $1M misses by $0.48MN/A
2022-10-26 21:09 ESTNewsOncoCyte: FDA's Regulatory Arm Might Pressure This MicrocapN/A
2022-08-31 00:47 ESTNewsOncocyte stock jumps ~15% after hours on contract for lung-cancer detection testN/A
2022-08-11 13:33 ESTNewsOncoCyte Corporation (OCX) CEO Ronnie Andrews on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 21:27 ESTNewsOncoCyte GAAP EPS of -$0.07 beats by $0.05, revenue of $2.1M misses by $0.66MN/A
2022-08-10 03:57 ESTNewsOncoCyte Q2 2022 Earnings PreviewN/A
2022-05-12 03:01 ESTNewsOncoCyte GAAP EPS of -$0.11 beats by $0.01, revenue of $1.43M misses by $0.81MN/A
2022-05-12 03:00 ESTNewsOncoCyte Corporation (OCX) CEO Ronnie Andrews on Q1 2022 Results - Earning Calls TranscriptN/A
2022-05-11 07:21 ESTNewsOncoCyte Q1 2022 Earnings PreviewN/A
2022-05-05 07:14 ESTNewsRevisiting OncoCyte Corp.N/A
2022-04-14 11:07 ESTNewsOncocyte stock slumps on pricing $35M securities offeringN/A
2022-04-13 21:02 ESTNewsOncoCyte announces offering of common stock, warrants, no amount givenN/A
2022-03-11 15:46 ESTNewsOncoCyte Corporation (OCX) CEO Ronnie Andrews on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-11 15:46 ESTNewsOncoCyte Corporation 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-10 19:56 ESTNewsOncoCyte GAAP EPS of -$0.39 misses by $0.26, revenue of $3.5M misses by $0.02MN/A
2022-03-10 03:27 ESTNewsOncoCyte Q4 2021 Earnings PreviewN/A
2022-01-19 15:59 ESTNewsFollowing agreement with Thermo Fisher, Oncocyte shares plunge 24%N/A
2022-01-19 00:54 ESTNewsOncocyte and Thermo Fisher Scientific to expand access to precision oncologyN/A
2021-12-10 00:36 ESTNewsOncocyte test can help predict patient response to breast cancer immunotherapyN/A
2021-11-10 13:19 ESTNewsOncoCyte EPS misses by $0.03, misses on revenueN/A
2021-11-10 13:19 ESTNewsOncoCyte's (OCX) CEO Ronnie Andrews on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:12 ESTNewsOncoCyte Q3 2021 Earnings PreviewN/A
2021-10-27 23:29 ESTNewsOncocyte gets US patent linked to early detection of organ transplant rejectionN/A
2021-10-12 10:43 ESTNewsWarning: OCX is at high risk of performing badlyN/A
2021-10-07 16:26 ESTNewsOncocyte taps Gisela Paulsen as COON/A
2021-10-06 14:02 ESTNewsOCX is at high risk of performing badlyN/A
2021-09-30 19:55 ESTNewsOncocyte's DetermaIO test shows potential to predict triple negative breast cancerN/A
2021-09-22 02:28 ESTNewsOncoCyte highlights potential of DetermaIO as a precision diagnostic in breast cancerN/A
2021-08-17 18:22 ESTNewsOncocyte launches real-world registry for certain patients with lung cancerN/A
2021-08-11 05:46 ESTNewsOncoCyte EPS misses by $0.02, beats on revenueN/A
2021-08-11 05:46 ESTNewsOncocyte Corporation (OCX) CEO Ronnie Andrews on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:14 ESTNewsOncocyte teams up with Italian research group to evaluate DetermaIO in colorectal cancerN/A
2021-07-21 18:13 ESTNewsPROG, KNDI, RIGL and FIXX among after-hours moversN/A
2021-07-21 18:03 ESTNewsOncoCyte signs an at-the-market agreement to sell $50M of common stockN/A
2021-07-21 18:02 ESTNewsOncocyte in pact with Echelon Diagnostics to support commercial expansion of testsN/A
2021-04-11 12:34 ESTNewsOncocyte’s DetermaIO shows correlation with immunotherapy response in bladder cancerN/A
2021-03-24 22:54 ESTNewsOncocyte CEO discloses insider buyingN/A
2021-03-19 00:03 ESTNewsOncoCyte Corporation 2021 Q1 - Results - Earnings Call PresentationN/A
2021-03-18 13:18 ESTAnalyst RatingThe Analyst Target Price has increased from $6.43 to $7.71.Buy

About OncoCyte Corporation Common Stock (OCX):

OncoCyte Corporation engages in the development and commercialization of proprietary laboratory-developed tests for the detection of cancer. The company offers DetermaRx, a molecular tests for early stage adenocarcinoma of the lung; and DetermaIO, a novel gene expression-based tests. It also develops DetermaDx, a non-invasive blood-based tests used to detect lung cancer. OncoCyte Corporation has a strategic collaboration with Guardian Research Network, Inc. to create a solution for pharma clients from patient recruitment to regulatory approvals. The company was founded in 2009 and is headquartered in Irvine, California.

OCX Quotes by TradingView

See Advanced Chart

General

  • Name OncoCyte Corporation Common Stock
  • Symbol OCX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Fiscal Year EndDecember
  • IPO Date2016-01-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.oncocyte.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 414.81
  • Price/Book (Most Recent Quarter) 12.15
  • Enterprise Value Revenue 587.1
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.38
  • Next Year EPS Estimate -$0.31
  • Next Quarter EPS Estimate -$0.10
  • Operating Margin -2773%
  • Return on Assets -44%
  • Return on Equity -93%
  • Revenue 1.22 million
  • Earnings Per Share -$0.37
  • Revenue Per Share $0.02
  • Gross Profit -639000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 427.01 million
  • EBITDA -15727000
  • PE Ratio -0.74
  • Analyst Target Price $7.71
  • Book Value Per Share $0.48
View More

Share Statistics

  • Shares Outstanding 88.59 million
  • Shares Float 39.26 million
  • % Held by Insiders 1573%
  • % Held by Institutions 46.27%
  • Shares Short 1.98 million
  • Shares Short Prior Month 1.99 million
  • Short Ratio 1.29
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.95
  • 52 Week High $6.57
  • 52 Week Low $1.15
  • 50 Day Moving Average 5.24
  • 200 Day Moving Average 2.84
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

OncoCyte Corporation Common Stock (OCX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

OncoCyte Corporation Common Stock (OCX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-23$N/A-$0.09-$0.1118.18%
2020-09-302020-11-12$555000-$0.13-$0.09-37.39%
2020-06-302020-07-29$N/A-$0.13-$0.10-28.98%
2020-03-312020-05-12$16000-$0.13-$0.11-17.92%
2019-12-312020-03-25$N/A-$0.14-$0.09-61.93%
2019-09-302019-11-14$N/A-$0.10-$0.08-20.73%
2019-06-302019-08-14$N/A-$0.10-$0.09-13.02%
2019-03-312019-05-14$N/A-$0.08-$0.098.14%
2018-12-312018-12-31$N/A-$0.11-$0.08-37.5%
2018-09-302018-11-13$N/A-$0.08-$0.097.73%
2018-06-302018-08-14$N/A-$0.09-$0.09-1.29%
2018-03-312018-04-02$N/A-$0.13-$0.132.48%
2017-12-312018-03-01$N/A-$0.13-$0.130%
2017-09-302017-11-14$N/A-$0.13-$0.130.08%
2017-06-302017-08-14$N/A-$0.13-$0.12-11.4%
2017-03-312017-04-28$N/A-$0.12-$0.12-3.33%
2016-12-312017-02-27$N/A-$0.10-$0.100%
2016-09-302016-11-10$N/A-$0.10-$0.100%
2016-06-302016-08-11$N/A-$0.10-$0.116.28%
2016-03-312016-05-16$N/A-$0.12-$0.137.69%
2015-12-312016-03-30$N/A-$0.16-$0.09-77.78%

OncoCyte Corporation Common Stock (OCX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

OncoCyte Corporation Common Stock (OCX) Chart:

OncoCyte Corporation Common Stock (OCX) News:

Below you will find a list of latest news for OncoCyte Corporation Common Stock (OCX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

OncoCyte Corporation Common Stock (OCX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest OCX Trades:

Date Shares Price
Jun 13, 2022 7:55 PM EST2$1.115
Jun 13, 2022 7:55 PM EST400$1.115
Jun 13, 2022 7:56 PM EST100$1.115
Jun 13, 2022 7:58 PM EST60$1.12
Jun 13, 2022 7:58 PM EST13$1.115

OncoCyte Corporation Common Stock (OCX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220012396/0001493152-20-012396-index.htm
2019-06-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642380/000000000019009713/0000000000-19-009713-index.htm
2020-05-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642380/000000000020004184/0000000000-20-004184-index.htm
2020-05-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642380/000000000020004669/0000000000-20-004669-index.htm
2020-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642380/000000000020007232/0000000000-20-007232-index.htm
2019-02-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000091957419001036/0000919574-19-001036-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957419001040/0000919574-19-001040-index.htm
2019-07-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000091957419004412/0000919574-19-004412-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957419004414/0000919574-19-004414-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957419005862/0000919574-19-005862-index.htm
2019-09-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000091957419005867/0000919574-19-005867-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957419007324/0000919574-19-007324-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957420000098/0000919574-20-000098-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000091957420003043/0000919574-20-003043-index.htm
2019-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642380/000119312519153162/0001193125-19-153162-index.htm
2018-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118047233/0001209191-18-047233-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118049408/0001209191-18-049408-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118049410/0001209191-18-049410-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118049412/0001209191-18-049412-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118049414/0001209191-18-049414-index.htm
2018-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919118049416/0001209191-18-049416-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119014338/0001209191-19-014338-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119020133/0001209191-19-020133-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119020135/0001209191-19-020135-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119020138/0001209191-19-020138-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119020142/0001209191-19-020142-index.htm
2019-06-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119034085/0001209191-19-034085-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119041282/0001209191-19-041282-index.htm
2019-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119041335/0001209191-19-041335-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119042836/0001209191-19-042836-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119042841/0001209191-19-042841-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119042845/0001209191-19-042845-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119042847/0001209191-19-042847-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119042849/0001209191-19-042849-index.htm
2019-07-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119043433/0001209191-19-043433-index.htm
2019-08-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119047153/0001209191-19-047153-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119049377/0001209191-19-049377-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119049683/0001209191-19-049683-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000120919119050090/0001209191-19-050090-index.htm
2018-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315218010764/0001493152-18-010764-index.htm
2018-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315218010765/0001493152-18-010765-index.htm
2018-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315218010766/0001493152-18-010766-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218010802/0001493152-18-010802-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218011262/0001493152-18-011262-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218011784/0001493152-18-011784-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315218011807/0001493152-18-011807-index.htm
2018-08-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000149315218012450/0001493152-18-012450-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218012669/0001493152-18-012669-index.htm
2018-08-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1642380/000149315218012746/0001493152-18-012746-index.htm
2018-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218014752/0001493152-18-014752-index.htm
2018-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218014918/0001493152-18-014918-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315218015750/0001493152-18-015750-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315218015756/0001493152-18-015756-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219001037/0001493152-19-001037-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219001058/0001493152-19-001058-index.htm
2019-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219001551/0001493152-19-001551-index.htm
2019-02-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219001572/0001493152-19-001572-index.htm
2019-02-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219001644/0001493152-19-001644-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219001773/0001493152-19-001773-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219003652/0001493152-19-003652-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219004542/0001493152-19-004542-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642380/000149315219004549/0001493152-19-004549-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219005637/0001493152-19-005637-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642380/000149315219006166/0001493152-19-006166-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219007082/0001493152-19-007082-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219007091/0001493152-19-007091-index.htm
2019-06-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642380/000149315219008772/0001493152-19-008772-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219008776/0001493152-19-008776-index.htm
2019-06-07PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1642380/000149315219008828/0001493152-19-008828-index.htm
2019-06-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642380/000149315219009263/0001493152-19-009263-index.htm
2019-06-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1642380/000149315219009345/0001493152-19-009345-index.htm
2019-06-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1642380/000149315219009350/0001493152-19-009350-index.htm
2019-06-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1642380/000149315219009750/0001493152-19-009750-index.htm
2019-07-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000149315219010320/0001493152-19-010320-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219010361/0001493152-19-010361-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219010977/0001493152-19-010977-index.htm
2019-07-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1642380/000149315219010981/0001493152-19-010981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219012526/0001493152-19-012526-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219012536/0001493152-19-012536-index.htm
2019-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219012811/0001493152-19-012811-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219013712/0001493152-19-013712-index.htm
2019-09-058-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219013745/0001493152-19-013745-index.htm
2019-09-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000149315219014106/0001493152-19-014106-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315219014109/0001493152-19-014109-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219014917/0001493152-19-014917-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219015754/0001493152-19-015754-index.htm
2019-11-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219017141/0001493152-19-017141-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219017142/0001493152-19-017142-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219017451/0001493152-19-017451-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315219017464/0001493152-19-017464-index.htm
2019-11-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642380/000149315219018210/0001493152-19-018210-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315219019778/0001493152-19-019778-index.htm
2020-01-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000149315220000239/0001493152-20-000239-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220000240/0001493152-20-000240-index.htm
2020-01-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315220000252/0001493152-20-000252-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220000253/0001493152-20-000253-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220000468/0001493152-20-000468-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220001618/0001493152-20-001618-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002153/0001493152-20-002153-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002154/0001493152-20-002154-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002155/0001493152-20-002155-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002156/0001493152-20-002156-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002320/0001493152-20-002320-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220002448/0001493152-20-002448-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220003525/0001493152-20-003525-index.htm
2020-03-178-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220004170/0001493152-20-004170-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315220004433/0001493152-20-004433-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220004444/0001493152-20-004444-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220004723/0001493152-20-004723-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642380/000149315220004738/0001493152-20-004738-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220005608/0001493152-20-005608-index.htm
2020-04-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220005646/0001493152-20-005646-index.htm
2020-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220005732/0001493152-20-005732-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220006754/0001493152-20-006754-index.htm
2020-04-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1642380/000149315220007177/0001493152-20-007177-index.htm
2020-04-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007179/0001493152-20-007179-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007187/0001493152-20-007187-index.htm
2020-04-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007247/0001493152-20-007247-index.htm
2020-04-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007249/0001493152-20-007249-index.htm
2020-04-2810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642380/000149315220007252/0001493152-20-007252-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007389/0001493152-20-007389-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007476/0001493152-20-007476-index.htm
2020-04-304/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220007488/0001493152-20-007488-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220008357/0001493152-20-008357-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315220008385/0001493152-20-008385-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220008386/0001493152-20-008386-index.htm
2020-05-18PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220009247/0001493152-20-009247-index.htm
2020-05-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642380/000149315220009249/0001493152-20-009249-index.htm
2020-05-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220009826/0001493152-20-009826-index.htm
2020-05-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1642380/000149315220009827/0001493152-20-009827-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011320/0001493152-20-011320-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011429/0001493152-20-011429-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011539/0001493152-20-011539-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011541/0001493152-20-011541-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011542/0001493152-20-011542-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011543/0001493152-20-011543-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220011545/0001493152-20-011545-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220012396/0001493152-20-012396-index.htm
2020-07-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642380/000149315220014178/0001493152-20-014178-index.htm
2020-07-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642380/000149315220014245/0001493152-20-014245-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220014247/0001493152-20-014247-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220014611/0001493152-20-014611-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220014613/0001493152-20-014613-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220014770/0001493152-20-014770-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220014772/0001493152-20-014772-index.htm
2020-08-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642380/000149315220016090/0001493152-20-016090-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220016812/0001493152-20-016812-index.htm
2020-08-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000149315220017045/0001493152-20-017045-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642380/000149315220018413/0001493152-20-018413-index.htm
2020-02-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1642380/000164238020000003/0001642380-20-000003-index.htm
2019-06-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642380/999999999519001369/9999999995-19-001369-index.htm
2020-08-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642380/999999999520002210/9999999995-20-002210-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1642380/999999999720000563/9999999997-20-000563-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1642380/999999999720000792/9999999997-20-000792-index.htm

OncoCyte Corporation Common Stock (OCX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OncoCyte Corporation Common Stock (OCX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1573%
Institutional Ownership: 4627%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-12Mitchell S LevineChief Financial OfficerBuy10,000.002.0120,060.0010,000.00https://www.sec.gov/Archives/edgar/data/1642380/000120919119049377/0001209191-19-049377-index.htm
2019-09-13TONY T KALAJIANSVP-Chief Accounting OfficerBuy10,000.001.9819,800.0010,000.00https://www.sec.gov/Archives/edgar/data/1642380/000120919119049683/0001209191-19-049683-index.htm
2019-09-17Andrew ArnoDirectorBuy50,000.002.16108,130.00102,447.00https://www.sec.gov/Archives/edgar/data/1642380/000120919119050090/0001209191-19-050090-index.htm
2020-08-03RONALD ASBURY ANDREWSChief Executive OfficerBuy40,000.001.3553,880.00102,698.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220014613/0001493152-20-014613-index.htm
2019-09-11BROADWOOD PARTNERS, L.P.10% Share HolderBuy0.0011,098,267.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419005862/0000919574-19-005862-index.htm
2019-09-11BROADWOOD PARTNERS, L.P.10% Share HolderBuy2,000,000.001.663,320,000.0011,098,267.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419005862/0000919574-19-005862-index.htm
2019-11-13BROADWOOD PARTNERS, L.P.10% Share HolderBuy0.0012,274,738.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419007324/0000919574-19-007324-index.htm
2019-11-13BROADWOOD PARTNERS, L.P.10% Share HolderBuy1,176,471.001.702,000,000.7012,274,738.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419007324/0000919574-19-007324-index.htm
2019-07-05BIOTIME INC10% Share HolderSell2,250,000.002.004,500,000.0012,424,244.00https://www.sec.gov/Archives/edgar/data/1642380/000120919119041335/0001209191-19-041335-index.htm
2020-01-02BROADWOOD PARTNERS, L.P.10% Share HolderBuy0.0013,043,114.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420000098/0000919574-20-000098-index.htm
2020-01-02BROADWOOD PARTNERS, L.P.10% Share HolderBuy768,376.002.161,656,618.6613,043,114.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420000098/0000919574-20-000098-index.htm
2020-01-02BROADWOOD PARTNERS, L.P.10% Share HolderBuy0.0013,666,204.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420000098/0000919574-20-000098-index.htm
2020-01-02BROADWOOD PARTNERS, L.P.10% Share HolderBuy623,090.002.161,343,382.0413,666,204.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420000098/0000919574-20-000098-index.htm
2020-04-24BROADWOOD PARTNERS, L.P.10% Share HolderBuy0.0014,716,204.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420003043/0000919574-20-003043-index.htm
2020-04-24BROADWOOD PARTNERS, L.P.10% Share HolderBuy1,050,000.002.272,383,500.0014,716,204.00https://www.sec.gov/Archives/edgar/data/1642380/000091957420003043/0000919574-20-003043-index.htm
2020-08-03TONY T KALAJIANSr.VP/Chief Accounting OfficerBuy5,000.001.316,533.0015,000.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220014770/0001493152-20-014770-index.htm
2018-07-26RONALD ASBURY ANDREWSDirectorBuy17,482.0017,482.00https://www.sec.gov/Archives/edgar/data/1642380/000149315218010765/0001493152-18-010765-index.htm
2020-03-14Mitchell S LevineChief Financial OfficerBuy20,000.0033,495.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220006754/0001493152-20-006754-index.htm
2018-07-26Mitchell S LevineChief Financial OfficerBuy3,495.003,495.00https://www.sec.gov/Archives/edgar/data/1642380/000149315218010764/0001493152-18-010764-index.htm
2018-07-26WILLIAM ANNETTPresident and CEOBuy3,500.003,500.00https://www.sec.gov/Archives/edgar/data/1642380/000149315218010766/0001493152-18-010766-index.htm
2020-08-03Mitchell S LevineChief Financial OfficerBuy10,000.001.3213,200.0036,579.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220014611/0001493152-20-014611-index.htm
2020-03-30RONALD ASBURY ANDREWSCEO and PresidentBuy27,216.002.2661,453.7344,698.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220005608/0001493152-20-005608-index.htm
2020-08-03Albert P ParkerChief Operating OfficerBuy5,000.001.336,648.005,000.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220014772/0001493152-20-014772-index.htm
2020-01-02Lineage Cell Therapeutics, Inc.InsiderSell2,383,090.002.165,137,942.046,041,154.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220000240/0001493152-20-000240-index.htm
2020-03-31RONALD ASBURY ANDREWSCEO and PresidentBuy18,000.002,372.0042,696,000.0062,698.00https://www.sec.gov/Archives/edgar/data/1642380/000149315220005608/0001493152-20-005608-index.htm
2019-02-08BROADWOOD PARTNERS, L.P.10% Share HolderBuy533,333.003.751,999,998.758,098,267.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419001040/0000919574-19-001040-index.htm
2019-09-11Lineage Cell Therapeutics, Inc.10% Share HolderSell4,000,000.001.666,640,000.008,424,244.00https://www.sec.gov/Archives/edgar/data/1642380/000149315219014109/0001493152-19-014109-index.htm
2019-07-02BROADWOOD PARTNERS, L.P.10% Share HolderBuy1,000,000.002.002,000,000.009,098,267.00https://www.sec.gov/Archives/edgar/data/1642380/000091957419004414/0000919574-19-004414-index.htm